Evidence check: TCF7L2 in the context of Allergie

TCF7L2 is a well-established gene primarily associated with type 2 diabetes risk. Evidence for a direct link to allergies is weak. Some studies suggest a potential role in immune regulation via Wnt signaling, which can influence inflammatory pathways, but robust, reproducible associations between TCF7L2 variants and allergic conditions like hay fever, asthma, or atopic dermatitis are lacking. Most genome-wide association studies (GWAS) for allergies identify other loci. A direct-to-consumer DNA test reporting TCF7L2 in an allergy context would be speculative and not evidence-based. No clinically actionable insights for allergy prevention or treatment can be derived. Caution: genetic tests for allergies should rely on validated markers. TCF7L2 remains primarily a diabetes gene.